Follow us...


Search News Archives

News Channels


New Laboratory Products

Lab News

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature


Events | Webinars



Conferences | Events


publication date: May 11, 2010
author/source: The Scott Partnership

Princeton, NJ - May 10, 2010 - PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that its subsidiaries Taylor Technology and Anapharm will be showcasing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at ASMS 2010 on May 22 - 27 in Salt Lake City, Utah.  We invite you to visit with our scientists at the various poster sessions throughout the meeting. 

Saturday May 22, 2010 - Sunday May 23, 2010

Richard LeLacheur, vice president, Taylor Technology, will teach his annual short course on High Resolution LC/MS for Structural Identification and Quantitation, where he will discuss the utility, advantages and limitations of conducting LC/MSn analysis using high resolution mass spectrometry.  

Taylor Technology and Anapharm representatives will be further demonstrating their offerings in method development and validation and bioanalytical mass spectrometry via a series of presentations covering a wide range of scientific topics including:  

Monday, May 24, 2010

Poster: How the Use of Incurred Samples is Important for the Validation of an Ultra Reproducible Assay for Exemestane, Presenter: Geneviéve Emond, Co-Authors: Nathalie Pelletier, Sylvain Lachance, Ann Levesque, Robert Massé 

Poster: The Importance of Stopping Enzymatic Activity in Plasma for Accurate Analysis of Fluorouracil by LC/MS/MS, Presenter: Nadia Savard, Co-Authors: Louis-Charles Boisvert, Marie Josee Marcoux, Ann Levesque, Robert Massé

Poster: Use of Adducts for Quantitation of Compounds by Liquid Chromatography Coupled with Tandem Mass Spectrometry Detection, Presenter: Jérome Bergeron, Co-Authors: Sebastien Gagne, Isabelle M. Levesque, Marie-Josee Marcoux, Ann Levesque, Robert Massé 

Tuesday, May 25, 2010

Presentation, 8:30 am: Beyond Successful ISR: Case by Case Investigations for Unmatched Reassay Results When ISR Passed, Presenter: Robert Massé, Vice President Bioanalysis, Anapharm will give a talk on incurred sample reassays (ISR), which currently is an important topic in the area of regulated bioanalysis, Co-Authors: Aimin Tan, Sylvain Lachance, Sofi Gagnon-Carignan, Ann Levesque 

Poster: Chromatographic Separation of Enogenous Level of Hypoxanthine for the Analysis of Allopurinol and Oxypurinol in Human Plasma in Gout Patients, Presenter: Valerie Montmigny Co-Authors: Nadine Lafontaine, Nathalie Pelletier, Sylvain Lachance, Ann Lévesque, Robert Massé 

Wednesday, May 26, 2010

Poster: Optimizing Tissue Analysis for LC-MS/MS in support of Drug Distribution Studies, Presenter: Nalini Anand, Co-Authors: Michael Koleto, Rohan Thakur, Tong Wu 

Thursday, May 27, 2010

Poster: Sample Collection Stability Issue when Dealing with Highly Bounded to Erythrocytes Molecules, Presenter: Nadia Savard, Co-Authors: Marie-Jose Marcoux, Sylvain Lachance, Ann Lévesque, Robert Massé 

Poster: Relative Instability of Deuterated Internal Standard under Different pH Conditions and According to Deuterium Atmos Location, Presenter: Guy Havard, Co-Authors: Marie-Ève Coulombe, Guy Havard, Sylvain Lachance, Ann Lévesque, Robert Massé 

Poster: Simultaneous Quantitation of Free and Liposomal Drug Forms in Human Serum by Evaporation-Free Extraction, Presenter: Francois Viel, Co-Authors: Nuno Santos, Aimin Tan, Lise Laforest, Nadine Boudreau, Ann Lévesque, Adrien Musuku, Robert Massé 

Poster: Robust and Ultra Sensitive Low Picograms Hormonal Contraceptive Determination by LCMSMS, Presenter: Guy Havard, Sylvain Lachance, Ann Lévesque, Robert Massé  

For more information about PharmaNet Development Group and its subsidiaries' complete range of services, please visit or e-mail 

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees throughout 34 countries, and 42 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development.  



Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd



Media Partners